General Information of Drug (ID: DMME40U)

Drug Name
LY-379268 Drug Info
Synonyms
LY 379268; LY-379268; CHEMBL275079; LY379268; 191471-52-0; SCHEMBL2454646; GTPL1394; (1R,4R,5S,6R)-4-Amino-2-oxabicyclo[3.1.0]hexane-4,6-dicarboxylic acid; CTK8F0567; DTXSID90436637; ZINC3952369; BDBM50074749; FCH888149; AKOS006306876; API0003234; NCGC00159572-01; LS-98795; RT-013615; LY-379,268; B7061; J-012378; 4-Amino-2-oxa-bicyclo[3.1.0]hexane-4,6-dicarboxylic acid; (1S,2R,5R,6R)-2-amino-4-oxabicyclo[3.1.0]hexane-2,6-dicarboxylic acid; (1R,4R,5S,6R)-4-Amino-2-oxa-bicyclo[3.1.0]hexane-4,6-dicarboxylic acid
Cross-matching ID
PubChem CID
10197984
ChEBI ID
CHEMBL275079
CAS Number
CAS 191471-52-0
TTD Drug ID
D07GRG

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
DNA replication 1.81 1.77e-1 34/36 (94.44%) PCNA;MCM4;RPA3;...
p53 signaling pathway 1.81 8.84e-2 63/73 (86.3%) CCNE2;RRM2;PERP;...
Prostate cancer 1.79 7.62e-2 93/97 (95.88%) CCNE2;PDGFD;PDGFRA;...
Hedgehog signaling pathway 1.68 1.69e-1 43/56 (76.79%) GAS1;PRKACB;GSK3B;...
FoxO signaling pathway 1.65 1.81e-1 118/131 (90.08%) SGK1;CDKN1B;PIK3CD;...
Glyoxylate and dicarboxylate metabolism 1.64 1.61e-1 23/30 (76.67%) DLD;SHMT1;ACAT1;...
Base excision repair 1.63 1.49e-1 29/33 (87.88%) PCNA;MBD4;NEIL1;...
IL-17 signaling pathway 1.62 1.57e-1 84/94 (89.36%) CXCL2;CXCL1;S100A8;...
Cell cycle 1.61 1.43e-1 110/124 (88.71%) CCNE2;PCNA;CDKN1B;...
Cellular senescence 1.56 1.95e-1 139/156 (89.1%) CCNE2;CXCL8;PIK3CD;...
Vasopressin-regulated water reabsorption 1.55 1.93e-1 40/44 (90.91%) AQP3;GNAS;PRKACB;...
Mismatch repair 1.53 2.15e-1 22/23 (95.65%) PCNA;RPA3
One carbon pool by folate 1.51 2.22e-1 15/20 (75%) ALDH1L1;SHMT1;MTHFD1;...
Progesterone-mediated oocyte maturation 1.51 2.07e-1 75/100 (75%) PRKACB;RPS6KA2;PIK3CD;...
Synthesis and degradation of ketone bodies 1.50 2.09e-1 9/10 (90%) HMGCS1;ACAT1;BDH2;...
MicroRNAs in cancer 1.47 2.70e-1 146/310 (47.1%) CCNE2;PDGFRA;FSCN1;...
Steroid biosynthesis 1.47 2.59e-1 19/20 (95%) DHCR24;CYP51A1;LSS;...
Notch signaling pathway 1.46 2.53e-1 49/59 (83.05%) JAG1;TLE4;KAT2B;...
Signaling pathways regulating pluripotency of stem cell... 1.45 2.57e-1 110/143 (76.92%) IL6ST;WNT5A;PIK3CD;...
Melanoma 1.45 2.46e-1 68/72 (94.44%) PDGFD;PDGFRA;PIK3CD;...
Oocyte meiosis 1.44 2.71e-1 90/129 (69.77%) CCNE2;PRKACB;RPS6KA2;...
Pentose and glucuronate interconversions 1.43 2.77e-1 17/34 (50%) UGDH;DCXR;UGT2B28;...
NF-kappa B signaling pathway 1.43 2.67e-1 90/104 (86.54%) CXCL12;CXCL2;CXCL1;...
Citrate cycle (TCA cycle) 1.42 2.57e-1 30/30 (100%) DLD;SUCLG2;PC;...
Legionellosis 1.42 2.53e-1 51/57 (89.47%) CXCL2;CXCL1;CXCL8;...
Viral carcinogenesis 1.42 2.55e-1 149/203 (73.4%) CCNE2;PRKACB;CDKN1B;...
AMPK signaling pathway 1.41 2.48e-1 106/120 (88.33%) LEPR;PIK3CD;PFKFB3;...
Rheumatoid arthritis 1.41 2.50e-1 78/93 (83.87%) CXCL12;CXCL2;CXCL1;...
Glycolysis / Gluconeogenesis 1.40 2.48e-1 56/67 (83.58%) GPI;DLD;ALDOB;...
Starch and sucrose metabolism 1.38 2.82e-1 25/36 (69.44%) GBE1;GPI;AGL;...
Ribosome -1.37 2.41e-1 113/158 (71.52%) RPS6;RPL10L;RPL13;...
Antigen processing and presentation -1.37 2.44e-1 60/78 (76.92%) KIR2DL4;TAP1;HLA-DPB1;...
Hepatitis C -1.37 2.50e-1 139/157 (88.54%) IKBKE;CLDN5;CHUK;...
ECM-receptor interaction -1.38 2.51e-1 80/88 (90.91%) COL4A3;COL4A2;ITGB1;...
Pantothenate and CoA biosynthesis -1.38 2.49e-1 14/21 (66.67%) ALDH3A2;DPYD;PPCDC;...
GnRH secretion -1.39 2.42e-1 60/64 (93.75%) ARRB1;KRAS;GPER1;...
Circadian rhythm -1.40 2.42e-1 26/31 (83.87%) PRKAB1;PRKAG1;NPAS2;...
Synaptic vesicle cycle -1.40 2.46e-1 63/78 (80.77%) ATP6V1H;SLC18A1;SLC1A1;...
Hematopoietic cell lineage -1.43 2.19e-1 90/99 (90.91%) ITGB3;CSF1R;HLA-DMB;...
Type I diabetes mellitus -1.43 2.24e-1 38/43 (88.37%) TNF;CD86;PTPRN2;...
Steroid hormone biosynthesis -1.44 2.18e-1 43/61 (70.49%) UGT2A3;AKR1C1;CYP11B1;...
Fatty acid elongation -1.44 2.27e-1 19/27 (70.37%) ELOVL4;MECR;HACD3;...
Platelet activation -1.45 2.17e-1 106/124 (85.48%) P2RY1;MAPK3;GNA13;...
Vascular smooth muscle contraction -1.46 2.26e-1 113/133 (84.96%) KCNMB4;ACTA2;ROCK1;...
Coronavirus disease -1.46 2.27e-1 215/232 (92.67%) IFNA16;RPL15;MAPK3;...
Natural killer cell mediated cytotoxicity -1.48 2.13e-1 99/131 (75.57%) IFNA16;KIR2DL3;MAPK3;...
Primary immunodeficiency -1.48 2.26e-1 33/38 (86.84%) BTK;AICDA;RFXANK;...
Riboflavin metabolism -1.50 2.02e-1 7/8 (87.5%) BLVRB;RFK;ACP2;...
Graft-versus-host disease -1.51 2.11e-1 32/42 (76.19%) KIR2DL3;HLA-DMB;KIR2DL1;...
Selenocompound metabolism -1.52 2.04e-1 11/17 (64.71%) KYAT3;KYAT1;CTH;...
African trypanosomiasis -1.53 2.06e-1 32/37 (86.49%) LAMA4;APOL1;MYD88;...
PPAR signaling pathway -1.54 2.01e-1 66/74 (89.19%) ACSBG1;ACSL5;ACSL3;...
Nicotine addiction -1.55 2.00e-1 32/40 (80%) GABRE;GABRR2;GABRD;...
Allograft rejection -1.56 2.15e-1 32/38 (84.21%) TNF;CD86;PRF1;...
Toll-like receptor signaling pathway -1.59 1.72e-1 94/104 (90.38%) JUN;FADD;STAT1;...
Arachidonic acid metabolism -1.60 1.75e-1 48/61 (78.69%) GGT1;PLA2G5;ALOX12;...
Autoimmune thyroid disease -1.65 1.43e-1 46/53 (86.79%) IFNA10;CD28;IL10;...
Histidine metabolism -1.67 1.45e-1 16/22 (72.73%) AOC1;ALDH2;ALDH9A1;...
Neuroactive ligand-receptor interaction -1.68 1.75e-1 294/341 (86.22%) GRIA4;IAPP;GLRA2;...
Leishmaniasis -1.71 1.76e-1 67/77 (87.01%) TLR4;TGFB2;HLA-DPB1;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone marrow
Neuroblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
SH-SY5Y CVCL_0019 Homo sapiens 0.04uM - 10uM 24H
SK-N-SH CVCL_0531 Homo sapiens 0.04uM - 10uM 24H